Evidence map›Paper›PMID 40562754›Full record

ArticleNature communications2025

The mitochondrial methylation potential gates mitoribosome assembly.

Ruth I C Glasgow, Vivek Singh, Lucía Peña-Pérez, Alissa Wilhalm, Marco F Moedas, David Moore, Florian A Rosenberger, Xinping Li, Ilian Atanassov, Mira Saba and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ruth I C Glasgow *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Vivek Singh *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4656-3362
Lucía Peña-PérezCentre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5044-7754
Alissa WilhalmDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Marco F MoedasDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
David MooreDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Florian A RosenbergerDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4604-6170
Xinping LiMax-Planck Institute for Biology of Ageing, Cologne, Germany.
Ilian AtanassovMax-Planck Institute for Biology of Ageing, Cologne, Germany.ORCID http://orcid.org/0000-0001-8259-2545
Mira SabaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Miriam CipulloDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Joanna RorbachDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2891-2840
Anna WedellCentre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.
Christoph FreyerDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. christoph.freyer@ki.se.ORCID http://orcid.org/0000-0003-0418-1673
Alexey AmuntsUniversity of Münster, Münster, Germany. alexey.amunts@gmail.com.ORCID http://orcid.org/0000-0002-5302-1740
Anna WredenbergDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. anna.wredenberg@ki.se.ORCID http://orcid.org/0000-0002-2500-6121

Funding

Cancerfonden (Swedish Cancer Society) 21 1621 PjEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-2018-StG-805230Karolinska Institutet (Karolinska Institute) 2-190/2022Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) KAW2019.0109Novo Nordisk Foundation Center for Basic Metabolic Research (NovoNordisk Foundation Center for Basic Metabolic Research) NN0082202Vetenskapsrådet (Swedish Research Council) VR2022-01287, VR2023-07091
6 · The paper itself

Abstract

S-adenosylmethionine (SAM) is the principal methyl donor in cells and is essential for mitochondrial gene expression, influencing RNA modifications, translation, and ribosome biogenesis. Using direct long-read RNA sequencing in mouse tissues and embryonic fibroblasts, we show that processing of the mitochondrial ribosomal gene cluster fails in the absence of mitochondrial SAM, leading to an accumulation of unprocessed precursors. Proteomic analysis of ribosome fractions revealed these precursors associated with processing and assembly factors, indicating stalled biogenesis. Structural analysis by cryo-electron microscopy demonstrated that SAM-dependent methylation is required for peptidyl transferase centre formation during mitoribosome assembly. Our findings identify a critical role for SAM in coordinating mitoribosomal RNA processing and large subunit maturation, linking cellular methylation potential to mitochondrial translation capacity.

Indexed as

MitochondriaMitochondrial RibosomesS-AdenosylmethionineAnimalsCryoelectron MicroscopyFibroblastsMethylationMiceMitochondrial ProteinsProteomicsRibosomal ProteinsRNA Processing, Post-TranscriptionalMitochondrial ProteinsRibosomal ProteinsS-Adenosylmethionine

Identifiers

PMID40562754
PMCPMC12198368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.